Volumetric changes in hypothalamic subunits in patients with relapsing remitting multiple sclerosis

被引:4
|
作者
Genc, Baris [1 ]
Sen, Sedat [2 ]
Aslan, Kerim [2 ,3 ]
Incesu, Luetfi [3 ]
机构
[1] Samsun Educ & Res Hosp, Dept Radiol, TR-55060 Samsun, Turkiye
[2] Ondokuz Mayis Univ, Dept Neurol, Sch Med, Samsun, Turkiye
[3] Ondokuz Mayis Univ, Dept Radiol, Sch Med, Samsun, Turkiye
关键词
Relapsing remitting multiple sclerosis; Hypothalamus; Freesurfer; Brain atrophy; ADRENAL AXIS ACTIVITY; COGNITIVE FATIGUE; LESIONS;
D O I
10.1007/s00234-023-03122-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose Studies on hypothalamic changes in patients with relapsing remitting multiple sclerosis (RRMS) are very scarce, despite the fact that the relationship with the hypothalamus is frequently reported. The aim of the study was to determine the volume of the hypothalamic subunits and the total hypothalamus and its relationship with the total demyelinating lesion volume (TLV) and expanded disability status scale (EDSS) in RRMS patients. Methods In this cross-sectional study, anterior-superior, superior tubular, posterior hypothalamus, anterior-inferior, inferior tubular subunits of hypothalamus, and total hypothalamus volume were calculated, with fully automatic analysis methods using volumetric T1 images of 65 relapsed RRMS patients and 68 healthy controls (HC). Volume changes in the hypothalamus and its subunits in RRMS patients were examined using multivariate analysis of covariance (MANCOVA). The relationship of these volumes with EDSS and TLV was investigated by partial correlation analysis. Results There is volume reduction in total hypothalamus (F = 13.87, p < 0.001), anterior-superior (F = 19.2, p < 0.001), superior tubular (F = 10.1, p = 0.002) subunits, and posterior hypothalamus (F = 19.2, p < 0.001) volume in RRMS patients. EDSS correlates negatively with anterior-superior (p = 0.017, r = - 0.333), superior tubular subunits (p = 0.023, r = - 0.439), posterior hypothalamus (p < 0.001, r = - 0.511), and whole hypothalamus volume (p = 0.001, r = - 0.439). TLV correlates negatively with anterior superior (p < 0.001, r = - 0.565), anterior inferior (p = 0.002, r = - 0.431), superior tubular subunits (p = 0.002, r = - 0.432), posterior hypothalamus (p < 0.001, r = - 0.703), and whole hypothalamus (p < 0.001, r = - 0.627) volumes. Conclusion This study demonstrates a reduction in total hypothalamus volume, anterior-superior, superior tubular, and posterior hypothalamus in patients with RRMS. Anterior-superior and superior tubular subunit, posterior hypothalamus, and total hypothalamus volume were negatively correlated with TLV and EDSS scores.
引用
收藏
页码:899 / 905
页数:7
相关论文
共 50 条
  • [1] Volumetric changes in hypothalamic subunits in patients with relapsing remitting multiple sclerosis
    Barış Genç
    Sedat Şen
    Kerim Aslan
    Lütfi İncesu
    Neuroradiology, 2023, 65 : 899 - 905
  • [2] Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis
    Zellini, Francesco
    Niepel, Graham
    Tench, Christopher R.
    Constantinescu, Cris S.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (12) : 1442 - 1449
  • [3] Cognitive Impairment In Relapsing Remitting Multiple Sclerosis Patients
    Tuncer, Nese
    Midi, Ipek
    Feyzioglu, Aynur
    JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2012, 29 (03): : 444 - 457
  • [4] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
    Onder, Halil
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
  • [5] Comorbidity in in patients with relapsing-remitting multiple sclerosis.
    Somilo, O., V
    Makarov, S. O.
    Kalbus, O., I
    MEDICNI PERSPEKTIVI, 2024, 29 (03): : 137 - 143
  • [6] Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab
    Costa Arpin, Eva
    Garcia Sobrino, Tania
    Dominguez Vivero, Clara
    Amigo Jorrin, Maria del Campo
    Rodriguez Regal, Ana
    Prieto Gonzalez, Jose
    Lema Bouzas, Manuela
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2016, 6 (01) : 5 - 12
  • [7] Fatigue and brain atrophy in Egyptian patients with relapsing remitting multiple sclerosis
    Khedr, Eman M.
    Desoky, Tarek
    Gamea, Ayman
    Ezzeldin, Mohammed Y.
    Zaki, Ahmed F.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 63
  • [8] Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis
    Cobo-Calvo, Alvaro
    Bau, Laura
    Matas, Elisabet
    Romero-Pinel, Lucia
    Mane Martinez, M. Alba
    Majos, Carles
    Martinez Yelamos, Sergio
    EUROPEAN NEUROLOGY, 2015, 73 (3-4) : 220 - 229
  • [9] Pausing and fluency in speech of patients with relapsing-remitting multiple sclerosis
    Bona, Judit
    CLINICAL LINGUISTICS & PHONETICS, 2024, 38 (04) : 332 - 344
  • [10] Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load
    Quarantelli, M
    Ciarmiello, A
    Morra, VB
    Orefice, G
    Larobina, M
    Lanzillo, R
    Schiavone, V
    Salvatore, E
    Alfano, B
    Brunetti, A
    NEUROIMAGE, 2003, 18 (02) : 360 - 366